Long-Lived Antibody and B Cell Memory Responses to the Human Malaria Parasites, and
Antibodies constitute a critical component of the naturally acquired immunity that develops following frequent exposure to malaria. However, specific antibody titres have been reported to decline rapidly in the absence of reinfection, supporting the widely perceived notion that malaria infections fail to induce durable immunological memory responses. Currently, direct evidence for the presence or absence of immune memory to malaria is limited. In this study, we analysed the longevity of both antibody and B cell memory responses to malaria antigens among individuals who were living in an area of extremely low malaria transmission in northern Thailand, and who were known either to be malaria naïve or to have had a documented clinical attack of P. falciparum and/or P. vivax in the past 6 years. We found that exposure to malaria results in the generation of relatively avid antigen-specific antibodies and the establishment of populations of antigen-specific memory B cells in a significant proportion of malaria-exposed individuals. Both antibody and memory B cell responses to malaria antigens were stably maintained over time in the absence of reinfection. In a number of cases where antigen-specific antibodies were not detected in plasma, stable frequencies of antigen-specific memory B cells were nonetheless observed, suggesting that circulating memory B cells may be maintained independently of long-lived plasma cells. We conclude that infrequent malaria infections are capable of inducing long-lived antibody and memory B cell responses.
Vyšlo v časopise:
Long-Lived Antibody and B Cell Memory Responses to the Human Malaria Parasites, and. PLoS Pathog 6(2): e32767. doi:10.1371/journal.ppat.1000770
Kategorie:
Research Article
prolekare.web.journal.doi_sk:
https://doi.org/10.1371/journal.ppat.1000770
Souhrn
Antibodies constitute a critical component of the naturally acquired immunity that develops following frequent exposure to malaria. However, specific antibody titres have been reported to decline rapidly in the absence of reinfection, supporting the widely perceived notion that malaria infections fail to induce durable immunological memory responses. Currently, direct evidence for the presence or absence of immune memory to malaria is limited. In this study, we analysed the longevity of both antibody and B cell memory responses to malaria antigens among individuals who were living in an area of extremely low malaria transmission in northern Thailand, and who were known either to be malaria naïve or to have had a documented clinical attack of P. falciparum and/or P. vivax in the past 6 years. We found that exposure to malaria results in the generation of relatively avid antigen-specific antibodies and the establishment of populations of antigen-specific memory B cells in a significant proportion of malaria-exposed individuals. Both antibody and memory B cell responses to malaria antigens were stably maintained over time in the absence of reinfection. In a number of cases where antigen-specific antibodies were not detected in plasma, stable frequencies of antigen-specific memory B cells were nonetheless observed, suggesting that circulating memory B cells may be maintained independently of long-lived plasma cells. We conclude that infrequent malaria infections are capable of inducing long-lived antibody and memory B cell responses.
Zdroje
1. GuptaS
SnowRW
DonnellyCA
MarshK
NewboldC
1999 Immunity to non-cerebral severe malaria is acquired after one or two infections. Nat Med 5 340 343
2. WipasaJ
ElliottS
XuH
GoodMF
2002 Immunity to asexual blood stage malaria and vaccine approaches. Immunol Cell Biol 80 401 414
3. BeesonJG
OsierFH
EngwerdaCR
2008 Recent insights into humoral and cellular immune responses against malaria. Trends Parasitol 24 578 584
4. LanghorneJ
NdunguFM
SponaasAM
MarshK
2008 Immunity to malaria: more questions than answers. Nat Immunol 9 725 732
5. StruikSS
RileyEM
2004 Does malaria suffer from lack of memory? Immunol Rev 201 268 290
6. StephensR
AlbanoFR
QuinS
PascalBJ
HarrisonV
2005 Malaria-specific transgenic CD4(+) T cells protect immunodeficient mice from lethal infection and demonstrate requirement for a protective threshold of antibody production for parasite clearance. Blood 106 1676 1684
7. D'Imperio LimaMR
AlvarezJM
FurtadoGC
KipnisTL
CoutinhoA
1996 Ig-isotype patterns of primary and secondary B cell responses to Plasmodium chabaudi chabaudi correlate with IFN-gamma and IL-4 cytokine production with CD45RB expression by CD4+ spleen cells. Scand J Immunol 43 263 270
8. WykesMN
ZhouYH
LiuXQ
GoodMF
2005 Plasmodium yoelii can ablate vaccine-induced long-term protection in mice. J Immunol 175 2510 2516
9. CarvalhoLJ
Ferreira-da-CruzMF
Daniel-RibeiroCT
Pelajo-MachadoM
LenziHL
2007 Germinal center architecture disturbance during Plasmodium berghei ANKA infection in CBA mice. Malar J 6 59
10. TaylorRR
EganA
McGuinnessD
JepsonA
AdairR
1996 Selective recognition of malaria antigens by human serum antibodies is not genetically determined but demonstrates some features of clonal imprinting. Int Immunol 8 905 915
11. UdhayakumarV
KariukiS
KolczackM
GirmaM
RobertsJM
2001 Longitudinal study of natural immune responses to the Plasmodium falciparum apical membrane antigen (AMA-1) in a holoendemic region of malaria in western Kenya: Asembo Bay Cohort Project VIII. Am J Trop Med Hyg 65 100 107
12. DrakeleyCJ
CorranPH
ColemanPG
TongrenJE
McDonaldSL
2005 Estimating medium- and long-term trends in malaria transmission by using serological markers of malaria exposure. Proc Natl Acad Sci U S A 102 5108 5113
13. CavanaghDR
ElhassanIM
RoperC
RobinsonVJ
GihaH
1998 A longitudinal study of type-specific antibody responses to Plasmodium falciparum merozoite surface protein-1 in an area of unstable malaria in Sudan. J Immunol 161 347 359
14. DorfmanJR
BejonP
NdunguFM
LanghorneJ
KortokMM
2005 B cell memory to 3 Plasmodium falciparum blood-stage antigens in a malaria-endemic area. J Infect Dis 191 1623 1630
15. AkpoghenetaOJ
DuahNO
TettehKK
DunyoS
LanarDE
2008 Duration of naturally acquired antibody responses to blood-stage Plasmodium falciparum is age dependent and antigen specific. Infect Immun 76 1748 1755
16. AsitoAS
MoormannAM
KiprotichC
Ng'ang'aZW
Ploutz-SnyderR
2008 Alterations on peripheral B cell subsets following an acute uncomplicated clinical malaria infection in children. Malar J 7 238
17. KumarN
FolgarJP
LubegaP
1992 Recognition of Plasmodium falciparum asexual stage antigens by antibodies in sera from people exposed to Plasmodium vivax. Am J Trop Med Hyg 47 422 428
18. JangpatarapongsaK
SirichaisinthopJ
SattabongkotJ
CuiL
MontgomerySM
2006 Memory T cells protect against Plasmodium vivax infection. Microbes Infect 8 680 686
19. ZeveringY
KhamboonruangC
RungruengthanakitK
TungviboonchaiL
RuengpipattanapanJ
1994 Life-spans of human T-cell responses to determinants from the circumsporozoite proteins of Plasmodium falciparum and Plasmodium vivax. Proc Natl Acad Sci U S A 91 6118 6122
20. IgonetS
Vulliez-Le NormandB
FaureG
RiottotMM
KockenCH
2007 Cross-reactivity studies of an anti-Plasmodium vivax apical membrane antigen 1 monoclonal antibody: binding and structural characterisation. J Mol Biol 366 1523 1537
21. BrachoC
PerezH
1992 An immunocytochemical test for the diagnosis of antibodies to Plasmodium vivax. Parasite Immunol 14 481 487
22. KimYM
HwangHA
YunWS
KimSI
LeeKW
2004 Efficacy of the merozoite surface protein 1 of Plasmodium vivax as an antigen for ELISA to diagnose malaria. Yonsei Med J 45 129 134
23. PhanTG
PausD
ChanTD
TurnerML
NuttSL
2006 High affinity germinal center B cells are actively selected into the plasma cell compartment. J Exp Med 203 2419 2424
24. AdamsCL
MacleodMK
James Milner-WhiteE
AitkenR
GarsideP
2003 Complete analysis of the B-cell response to a protein antigen, from in vivo germinal centre formation to 3-D modelling of affinity maturation. Immunology 108 274 287
25. CrottyS
FelgnerP
DaviesH
GlidewellJ
VillarrealL
2003 Cutting edge: long-term B cell memory in humans after smallpox vaccination. J Immunol 171 4969 4973
26. LanghorneJ
CrossC
SeixasE
LiC
von der WeidT
1998 A role for B cells in the development of T cell helper function in a malaria infection in mice. Proc Natl Acad Sci U S A 95 1730 1734
27. PierceSK
MillerLH
2009 World Malaria Day 2009: what malaria knows about the immune system that immunologists still do not. J Immunol 182 5171 5177
28. KinyanjuiSM
BullP
NewboldCI
MarshK
2003 Kinetics of antibody responses to Plasmodium falciparum-infected erythrocyte variant surface antigens. J Infect Dis 187 667 674
29. PihlgrenM
FriedliM
TougneC
RochatAF
LambertPH
2006 Reduced ability of neonatal and early-life bone marrow stromal cells to support plasmablast survival. J Immunol 176 165 172
30. PihlgrenM
SchallertN
TougneC
BozzottiP
KovarikJ
2001 Delayed and deficient establishment of the long-term bone marrow plasma cell pool during early life. Eur J Immunol 31 939 946
31. StephensR
NdunguFM
LanghorneJ
2009 Germinal centre and marginal zone B cells expand quickly in a second Plasmodium chabaudi malaria infection producing mature plasma cells. Parasite Immunol 31 20 31
32. The Ministry of Public Health, Thailand 2003 Manual for Malaria Control; Bureau of Vector Borne Diseases, editor Bangkok The Agricultural Co-operative Federation of Thailand., Limited
33. Department of Disease Control, The Minstry of Public Health. Report on malaria cases. http://203.157.41.98/malaria/freereoprt/rep.php?free=1&PHPSESSID=368625f72ed8fbe6801903db82d4c152
34. ClutterbuckEA
OhS
HamalubaM
WestcarS
BeverleyPC
2008 Serotype-specific and age-dependent generation of pneumococcal polysaccharide-specific memory B-cell and antibody responses to immunization with a pneumococcal conjugate vaccine. Clin Vaccine Immunol 15 182 193
35. BuismanAM
de RondCG
OzturkK
Ten HulscherHI
van BinnendijkRS
2009 Long-term presence of memory B-cells specific for different vaccine components. Vaccine 28 179 86
36. ManzRA
HauserAE
HiepeF
RadbruchA
2005 Maintenance of serum antibody levels. Annu Rev Immunol 23 367 386
37. AmannaIJ
CarlsonNE
SlifkaMK
2007 Duration of humoral immunity to common viral and vaccine antigens. N Engl J Med 357 1903 1915
38. HopkinsRJ
KramerWG
BlackwelderWC
AshtekarM
HagueL
2004 Safety and pharmacokinetic evaluation of intravenous vaccinia immune globulin in healthy volunteers. Clin Infect Dis 39 759 766
39. BensonMJ
ElguetaR
SchperoW
MolloyM
ZhangW
2009 Distinction of the memory B cell response to cognate antigen versus bystander inflammatory signals. J Exp Med 206 2013 25
40. BernasconiNL
TraggiaiE
LanzavecchiaA
2002 Maintenance of serological memory by polyclonal activation of human memory B cells. Science 298 2199 2202
41. MontesCL
Acosta-RodriguezEV
MerinoMC
BermejoDA
GruppiA
2007 Polyclonal B cell activation in infections: infectious agents' devilry or defense mechanism of the host? J Leukoc Biol 82 1027 1032
42. MuehlinghausG
CiglianoL
HuehnS
PeddinghausA
LeyendeckersH
2005 Regulation of CXCR3 and CXCR4 expression during terminal differentiation of memory B cells into plasma cells. Blood 105 3965 3971
43. TokoyodaK
EgawaT
SugiyamaT
ChoiBI
NagasawaT
2004 Cellular niches controlling B lymphocyte behavior within bone marrow during development. Immunity 20 707 718
44. CromptonPD
MirceticM
WeissG
BaughmanA
HuangCY
2009 The TLR9 ligand CpG promotes the acquisition of Plasmodium falciparum-specific memory B cells in malaria-naive individuals. J Immunol 182 3318 3326
45. AlwaynIP
XuY
BaskerM
WuC
BuhlerL
2001 Effects of specific anti-B and/or anti-plasma cell immunotherapy on antibody production in baboons: depletion of CD20- and CD22-positive B cells does not result in significantly decreased production of anti-alphaGal antibody. Xenotransplantation 8 157 171
46. DiLilloDJ
HamaguchiY
UedaY
YangK
UchidaJ
2008 Maintenance of long-lived plasma cells and serological memory despite mature and memory B cell depletion during CD20 immunotherapy in mice. J Immunol 180 361 371
47. AnolikJH
BarnardJ
CappioneA
Pugh-BernardAE
FelgarRE
2004 Rituximab improves peripheral B cell abnormalities in human systemic lupus erythematosus. Arthritis Rheum 50 3580 3590
48. VallerskogT
GunnarssonI
WidheM
RisseladaA
KlareskogL
2007 Treatment with rituximab affects both the cellular and the humoral arm of the immune system in patients with SLE. Clin Immunol 122 62 74
49. Bouharoun-TayounH
AttanathP
SabchareonA
ChongsuphajaisiddhiT
DruilheP
1990 Antibodies that protect humans against Plasmodium falciparum blood stages do not on their own inhibit parasite growth and invasion in vitro, but act in cooperation with monocytes. J Exp Med 172 1633 1641
50. PierceSK
2009 Understanding B cell activation: from single molecule tracking, through Tolls, to stalking memory in malaria. Immunol Res 43 85 97
51. ThimasarnK
JatapadmaS
VijaykadgaS
SirichaisinthopJ
WongsrichanalaiC
1995 Epidemiology of Malaria in Thailand. J Travel Med 2 59 65
52. SnounouG
ViriyakosolS
ZhuXP
JarraW
PinheiroL
1993 High sensitivity of detection of human malaria parasites by the use of nested polymerase chain reaction. Mol Biochem Parasitol 61 315 320
53. BurghausPA
HolderAA
1994 Expression of the 19-kilodalton carboxy-terminal fragment of the Plasmodium falciparum merozoite surface protein-1 in Escherichia coli as a correctly folded protein. Mol Biochem Parasitol 64 165 169
54. TragerW
JensenJB
1976 Human malaria parasites in continuous culture. Science 193 673 675
55. EganAF
ChappelJA
BurghausPA
MorrisJS
McBrideJS
1995 Serum antibodies from malaria-exposed people recognize conserved epitopes formed by the two epidermal growth factor motifs of MSP1(19), the carboxy-terminal fragment of the major merozoite surface protein of Plasmodium falciparum. Infect Immun 63 456 466
56. VyseAJ
GayNJ
HeskethLM
PebodyR
Morgan-CapnerP
2006 Interpreting serological surveys using mixture models: the seroepidemiology of measles, mumps and rubella in England and Wales at the beginning of the 21st century. Epidemiol Infect 134 1303 1312
57. OhumaEO
OkiroEA
BettA
AbwaoJ
WereS
2009 Evaluation of a measles vaccine campaign by oral-fluid surveys in a rural Kenyan district: interpretation of antibody prevalence data using mixture models. Epidemiol Infect 137 227 233
Štítky
Hygiena a epidemiológia Infekčné lekárstvo LaboratóriumČlánok vyšiel v časopise
PLOS Pathogens
2010 Číslo 2
- Parazitičtí červi v terapii Crohnovy choroby a dalších zánětlivých autoimunitních onemocnění
- Očkování proti virové hemoragické horečce Ebola experimentální vakcínou rVSVDG-ZEBOV-GP
- Koronavirus hýbe světem: Víte jak se chránit a jak postupovat v případě podezření?
Najčítanejšie v tomto čísle
- Caspase-1 Activation via Rho GTPases: A Common Theme in Mucosal Infections?
- Kaposi's Sarcoma Associated Herpes Virus (KSHV) Induced COX-2: A Key Factor in Latency, Inflammation, Angiogenesis, Cell Survival and Invasion
- IL-1β Processing in Host Defense: Beyond the Inflammasomes
- Reverse Genetics in Predicts ARF Cycling Is Essential for Drug Resistance and Virulence